TD52 is an orally active inhibitor of cancerous inhibitor of PP2A (CIP2A). TD52 is an Erlotinib derivative and indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter.
Molecular Weight:
360.41
Purity:
99.92%
CAS Number:
[1798328-24-1]
Formula:
C24H16N4
Target:
Apoptosis|||Phosphatase|||Akt
T35528
* VAT and and shipping costs not included. Errors and price changes excepted